Overview of the Cannabis Industry

Overview of the Cannabis Industry

The Cannabis industry involves the cultivation, production, and sale of cannabis and cannabis-derived products for medicinal, recreational, and industrial purposes.

Market Growth

The global cannabis market was valued at approximately $20.5 billion in 2020 and is projected to reach $90.4 billion by 2026, growing at a CAGR of 28.0%.

Drivers of Industry Growth

The growth of this industry is driven by the increasing legalization and acceptance of cannabis for medicinal and recreational use, advancements in cultivation and extraction technologies, and the growing demand for cannabis-based products.

Impact on Society

The cannabis industry has a significant impact on society by providing new medical treatments, creating jobs, and generating tax revenue. Medicinal cannabis is used to treat various conditions, including chronic pain, epilepsy, multiple sclerosis, and anxiety, providing patients with an alternative to traditional pharmaceuticals.

Recreational Cannabis

Recreational cannabis offers consumers a legal and regulated option for adult use, reducing the illegal market and associated criminal activities.

Industrial Uses of Cannabis

The industrial use of cannabis, particularly hemp, includes the production of textiles, biofuels, and construction materials, promoting sustainability and innovation.

Effect of COVID-19 on Industry Adoption

The COVID-19 pandemic has accelerated the growth of the cannabis industry, as consumers seek alternative wellness products and governments recognize the economic potential of cannabis legalization.

Challenges in the Industry

However, the industry faces challenges related to regulatory compliance, stigma, and the need for research on the long-term effects of cannabis use.

Future of the Cannabis Industry

Despite these challenges, the potential benefits of cannabis innovations are significant, and continued investment and policy support are essential for driving growth in this sector. As the cannabis industry continues to evolve, it will play a crucial role in shaping the future of medicine, recreation, and industrial applications, promoting economic development and societal well-being.

overlay landing page

We found 104 VC firms in the United states investing in Cannabis on Angels Partners

  • main investor picture
    Daisy Mellet
    Partner
  • main investor picture
    David Goldburg
    Partner
  • main investor picture
    Mitch Baruchowitz
    Managing Partner
  • main investor picture
    Jeff Monat
    Partner
  • main investor picture
    Kevin Gibbs
    Partner
  • main investor picture
    Mina Mishrikey
    Partner
  • main investor picture
    Max Gerard
    Partner
Investor Picture
Previous Investments
  • Canndescent: $13000000 (Later stage VC)
  • Civilized:

Merida Capital Partners

New York City, U.S.A.

Investing In

Cannabis • Food & Beverage • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Life Science

Description

Merida Capital Partners is a private equity investment firm targeting fundamental growth and development of the cannabis industry. Their investment emphasis focuses on cultivation technologies, products and services associated with the evolution of cannabis as an agricultural product, a natural plant-based medicine, a constituent in pharmaceutical formulations, and a recreational consumer product.

main investor picture
Vulcan Capital
Investing in Software (Web Marketplace Saas..) &b...
 Bellevue Washington ,..., U.S.A.
  • main investor picture
    Steve Hall
    Venture Partner
  • main investor picture
    Abhishek Agrawal
    Senior Associate
  • main investor picture
    YB Choi
    Investor
  • main investor picture
    Stuart Nagae
    Investor
Investor Picture
Previous Investments
  • UNITY Biotechnology: $35000000 (Series B)
  • Oxygen Media: $100000000 (Later stage VC)
  • Caspian Networks: $85000000 (Later stage VC)
  • solarisBank: $67490000 (Later stage VC)
  • Cytokinetics, Inc.: $40000000 (Later stage VC)
  • PortalPlayer: $22000000 (Later stage VC)
  • Clean Fund: $15000000 (Later stage VC)
  • Versive: $12700000 (Later stage VC)
  • IFILM: $10000000 (Other)
  • Rocket Network: $9300000 (Later stage VC)
  • ICON Technology (Homebuilding): $9000000 (Early stage VC)
  • Make.TV Inc.: $8500000 (Later stage VC)
  • Pointy: $6000000 (Early stage VC)
  • Nomadic: $6000000 (Seed Round)
  • Against Gravity: $5000000 (Later stage VC)
  • Ryff: $5000000 (Early stage VC)
  • Blokable, Inc.: $4886194 (Later stage VC)
  • Grab: $2000000 (Seed Round)
  • Taunt: $1700000 (Seed Round)
  • Matcherino: $1500000 (Seed Round)
  • eStyle: $1139000 (Later stage VC)
  • TicketGuardian LLC: $500000 (Other)
  • Calxeda: $55000000 (Series C)
  • Omeros: $20000000 (Post Ipo Equity)
  • Infinia: $12000000 (Series Unknown)
  • Infinia: $7000000 (Series B)
  • Infinia: $50000000 (Series B)
  • Infinia: $10000000 (Series A)
  • Radar Networks: $13000000 (Series B)
  • Radar Networks: $5000000 (Series A)
  • AdaptX: $10000000 (Series B)
  • AdaptX: $6000000 (Series A)
  • Blokable: $6000000 (Series Unknown)
  • Rebellyous Foods: $20000000 (Series B)
  • Kevala: $12000000 (Series A)
  • Nifty Games: $26000000 (Series B)
  • Gentem: $10000000 (Series A)
  • Gentem: $4000000 (Seed)
  • AI.Reverie: $6000000 (Seed)
  • AI.Reverie: (Seed)
  • Prophia: $10000000 (Series A)
  • CivicEye: $12000000 (Series A)
  • Rad Power Bikes: $150000000 (Series D)
  • Rad Power Bikes: $150000000 (Series C)
  • Rad Power Bikes: $25000000 (Series B)
  • Voodle: $6000000 (Series A)
  • Nautilus Biotechnology: $76000000 (Series B)
  • Pixvana, Inc.: $14000000 (Series A)
  • Pixvana, Inc.: $6000000 (Seed)
  • 4INFO: $8000000 (Series Unknown)
  • 4INFO: $14000000 (Series Unknown)

Vulcan Capital

Bellevue Washington - California, U.S.A.

Investing In

Software (Web Marketplace Saas..) • PropTech • Other • IT (& TMT) • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • IoT (& Wearables) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Cannabis • Gaming (& eSports) • Cloud Services (& Infrastructure) • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Robotics • Real Estate (& Construction) • Healthcare (& Wellness) • LegalTech • Mobility • Consumer

Description

Vulcan Capital is a private equity and venture capital firm and investment arm of Paul Allen based in Seattle, Washington. The firm focuses on investing in all stages of corporate development through leveraged buyouts, growth capital, turnarounds and early-stage venture capital. The firm invests in the financial services, internet technology, life sciences, media, communication and consumer sectors. It was established in 2003 and operates as an investment arm of Vulcan.

main investor picture
Deerfield Management
Investing in Software (Web Marketplace Saas..) &b...
 New York City - Tel Aviv, U.S.A.
  • main investor picture
    Steve Anastos
    Principal
  • main investor picture
    Adam Greene
    Partner
  • main investor picture
    James Flynn
    Managing Partner
  • main investor picture
    Jean Kim
    Partner
  • main investor picture
    Andrew ElBardissi
    Partner
  • main investor picture
    Jason Fuller
    Partner
  • main investor picture
    Sumner Anderson
    Partner
  • main investor picture
    Brian Bizoza
    Partner
  • main investor picture
    Kevin Berg
    Partner
  • main investor picture
    Vince Mellet
    Partner
  • main investor picture
    Terence Karnal
    Partner
  • main investor picture
    Abraham Kometz
    Partner
  • main investor picture
    Adam Grossman
    Partner
  • main investor picture
    Alexis Cazé
    Partner
  • main investor picture
    Alison Stamas
    Associate
  • main investor picture
    Cameron Wheeler
    Partner
  • main investor picture
    Jonathan Leff
    Partner
  • main investor picture
    Julian Harris
    Partner
  • main investor picture
    Crystal Wright
    Associate
  • main investor picture
    Eddie Yang
    Analyst
  • main investor picture
    Elise Wang
    Partner
  • main investor picture
    Jackson Harvey
    Analyst
  • main investor picture
    Konstantinos Aprilakis
    Partner
  • main investor picture
    Peter Steelman
    Partner
  • main investor picture
    Veranika Razhkova
    Analyst
  • main investor picture
    Bharath Ganesan
    Principal
  • main investor picture
    Steven Hochberg
    Partner
  • main investor picture
    Gilan Megeed
    Principal
  • main investor picture
    Leslie Henshaw
    Partner
  • main investor picture
    Shumaila Irshad
    Analyst
  • main investor picture
    Vincent Mellet
    Partner
  • main investor picture
    Wenxi Chen
    Analyst
  • main investor picture
    Zheng Su
    Partner
Investor Picture
Previous Investments
  • Ardelyx: $110000000 (Other)
  • Recovery Centers of America: $100000000 (Other)
  • Oncorus, Inc.: $57000000 (Early stage VC)
  • Shockwave Medical: $45000000 (Later stage VC)
  • Fractyl Laboratories: $44000000 (Later stage VC)
  • Synlogic: $42000000 (Later stage VC)
  • SentreHEART: $35000000 (Later stage VC)
  • Phoenix Nuclear Labs: $12000000 (Later stage VC)
  • Cystetic Medicines: $3850000 (Early Stage VC)
  • Covagen: $66000000 (Series B)
  • Xlumena: $25000000 (Series C)
  • Xlumena: $7000000 (Series B)
  • MMI: $110000000 (Series C)
  • MMI: $75000000 (Series B)
  • Bitterroot Bio: $150000000 (Series A)
  • Epic Sciences: $24000000 (Series G)
  • Pleno: $40000000 (Series A)
  • Aurion Biotechnologies: $120000000 (Series Unknown)
  • V-Wave: $98000000 (Series C)
  • V-Wave: $28000000 (Series C)
  • V-Wave: $70000000 (Series C)
  • GeneDx: $120000000 (Series C)
  • Element Science: $150000000 (Series C)
  • Sollis Therapeutics: $50000000 (Series Unknown)
  • Nema Health: $15000000 (Series A)
  • Vesta Healthcare: $55000000 (Series C)
  • Vesta Healthcare: $65000000 (Series C)
  • Octave: $33000000 (Series B)
  • Octave: $32000000 (Series B)
  • Cortica: $75000000 (Series D)
  • Intus Care: $14000000 (Series A)
  • Somatus: $330000000 (Series E)
  • Somatus: $64000000 (Series C)
  • Lark: $100000000 (Series D)
  • Ready: $48000000 (Series B)
  • RubiconMD: $18000000 (Series C)
  • Pairwise Plants: $40000000 (Series C)
  • Pairwise Plants: $90000000 (Series B)
  • Pairwise Plants: $25000000 (Series A)
  • Perceive Biotherapeutics: $78000000 (Series B)
  • Vicinitas Therapeutics: $65000000 (Series A)
  • Ribon Therapeutics: $65000000 (Series C)
  • Nuvalent: $140000000 (Series B)
  • Nuvalent: $50000000 (Series A)
  • Neomorph: $110000000 (Series A)
  • Homology Medicines: $84000000 (Series B)
  • Homology Medicines: $44000000 (Series A)
  • Oncorus: $57000000 (Series A)
  • Blade Therapeutics: $45000000 (Series B)
  • Spectrawave: $50000000 (Series B)
  • Spectrawave: $13000000 (Series A)
  • HearMe: $2000000 (Series A)
  • Liquid Wire: $10000000 (Series A)
  • Meditrina: $10000000 (Series Unknown)
  • Phoenix: $12000000 (Series Unknown)
  • SHINE Technologies: $130000000 (Series Unknown)
  • Actio Biosciences: $55000000 (Series A)
  • Jounce Therapeutics: $47000000 (Series A)
  • BIOMx: $50000000 (Post Ipo Equity)
  • Adaptive Phage Therapeutics: $41000000 (Series B)
  • Mirum Pharmaceuticals: $120000000 (Series A)
  • AveXis: $65000000 (Series D)
  • AveXis: $10000000 (Series C)
  • Audentes Therapeutics: $43000000 (Series B)
  • Hana Biosciences: $100000000 (Private Equity)
  • Altus Pharmaceuticals: $51000000 (Series C)
  • Elion Therapeutics: $81000000 (Series B)
  • Jaguar Gene Therapy: $140000000 (Series B)
  • Jaguar Gene Therapy: (Series A)
  • Happify: $73000000 (Series D)
  • Great Lakes Discoveries LLC: $130000000 (Undisclosed)
  • ARTMS: $19000000 (Series A)
  • Four Points Innovation: $130000000 (Undisclosed)
  • The Johns Hopkins University: $65000000 (Series Unknown)
  • Infinity Pharmaceuticals: $100000000 (Post Ipo Debt)
  • MannKind: $160000000 (Post Ipo Debt)
  • Crossover Health: $170000000 (Series D)
  • Curation Health: (Series A)
  • Concert Genetics: (Series Unknown)
  • CambridgeSoft: $31000000 (Series Unknown)

Deerfield Management

New York City - Tel Aviv, U.S.A.

Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • Media • Education • BioTech • Businesses Solutions • FinTech (& Financials services) • HealthTech (& Fitness) • Cannabis • Gaming (& eSports) • Analytics • Cloud Services (& Infrastructure) • Material Science • Medical Devices (& Hospital Services) • Aerospace (& Defense) • Healthcare (& Wellness) • Investment Management • Life Science • Oncology • Consumer • Pharmaceutical (& Medicine)

Description

Deerfield Management is a venture capital firm which specializes in seed, early stage and later stage investments. The firm invests in the healthcare, pharmaceutical and biotechnology sectors. The firm is based in New York, New York with additional offices in Shanghai, China and Epalinges, Switzerland.

main investor picture
Square Peg Capital Pty Ltd.
Investing in Software (Web Marketplace Saas..) &b...
 Massachusetts, United States
Investor Picture
Previous Investments
  • ClimaCell Inc.: (early stage)
  • LifeBEAM: (mid stage)
  • Ready4: (mid stage)
  • Square Peg Capital: (mid stage)
  • Internet of Things, Digital Health, Social Apps:
  • ooVoo:

Square Peg Capital Pty Ltd.

Massachusetts, United States

Investing In

Software (Web Marketplace Saas..) • PropTech • Other • IT (& TMT) • Hospitality (& Events) • Media • Education • BioTech • AgroTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • Sales (& Marketing) • Cosmetics (& Fashion) • Entertainment (& Sports) • IoT (& Wearables) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Cannabis • Blockchain (& Cryptos) • Web Security (& Privacy) • Gaming (& eSports) • Advertising • Analytics • AR/VR • Autonomous vehicles (& Cars) • Cloud Services (& Infrastructure) • Developer tools • Future Of Work • Food & Beverage • GovTech • Human Resources • Impact • Insurance (& InsurTech) • Local commerce • Logistics (& Distribution) • Material Science • Medical Devices (& Hospital Services) • Messaging • Payments • Robotics • Mobile Apps • Aerospace (& Defense) • Real Estate (& Construction) • SaaS

Description

Partner at Square Peg Capital

Partner at Square Peg Capital

Investor Picture
Previous Investments
  • StormSensor: $1200000
  • StormSensor:

E8

Seattle, U.S.A.

Investing In

IT (& TMT) • CleanTech • Cannabis

Description

Element 8 is a member organization of private and accredited angel investors. The firm invests in early stage companies operating in the clean technology, energy and information technology sectors. It is based in Seattle, Washington and was founded in 2006.

main investor picture
Canrock Ventures
Investing in Software (Web Marketplace Saas..) &b...
 New York City, U.S.A.
  • main investor picture
    Jim Estill
    Partner
  • main investor picture
    Mark Fasciano
    Partner
Investor Picture
Previous Investments
  • Plum (Human Capital Services): $2200000 (Seed Round)
  • CooCoo: $1000000 (Early stage VC)
  • Tacit Innovations: $700000 (Seed Round)
  • Sentiment Alpha: $410000 (Later stage VC)
  • Crowdster: $398000 (Later stage VC)
  • Vidaao: $300000 (Seed Round)
  • ViewsIQ: $40000 (Seed Round)
  • BuildCircle: $40000 (Seed Round)
  • Plum.io: (Early stage VC)
  • Honestly Now: (Seed Round)

Canrock Ventures

New York City, U.S.A.

Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • FinTech (& Financials services) • Cannabis • Advertising • Investment Management • Mobile • Oil & Gas (& Mining)

Description

Canrock Ventures is an technology focused venture capital firm and incubator located in Long Island, NY. Canrock takes a 40-80% equity stake for early investment ($500k-$1.5m), making it possible to reach 5-10x target returns. Since its inception, Canrock has raised over $400 million for startup companies, with 20 exits and attaining a total market value of $4.1 billion.

main investor picture
Montlake Capital
Investing in Software (Web Marketplace Saas..) &b...
 Seattle, Washington, U.S.A.
  • main investor picture
    Vivian Loh Nahmias
    CFO
  • main investor picture
    Andy Dale
    Managing Director
  • main investor picture
    Noel de Turenne
    Managing Director
  • main investor picture
    Andrew Dale
    Partner
  • main investor picture
    Noel Turenne
    Partner
Investor Picture
Previous Investments
  • Wellpartner: $16100000 (Later stage VC)
  • PayScale: $10300000 (Later stage VC)
  • ClearAccess: $6000000 (Later stage VC)
  • Vanson HaloSource: $5000000 (Later stage VC)
  • Intrepid Learning, Inc.: $4250000 (Later stage VC)
  • Max Viz:
  • Escapia: $2000000 (Later stage VC)
  • Fast Water Heater Company:
  • Theo Chocolate:
  • Fedelta Home Care:

Montlake Capital

Seattle, Washington, U.S.A.

Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • Education • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • HealthTech (& Fitness) • Cannabis • Food & Beverage • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Investment Management • Mobile

Description

Montlake Capital is a growth equity investment firm based in Seattle, Washington. The firm invests in the consumer and business products and services, financial services and technology sectors located in the Western United States, with a preference for the Pacific Northwest and Rocky Mountains.

Investor Picture
Previous Investments
  • Baseline Energy Services:

Alturus Strategic Capital Partners

Dallas, U.S.A.

Investing In

CleanTech • Cannabis

Description

Alturus Strategic Capital Partners is a Dallas, Texas based strategic capital provider that focuses on middle-market companies. The firm invests in business services, consumer, distribution and logistics, energy services and specialty manufacturing sectors.

Investor Picture
Previous Investments
  • Vertosa:

AFI Capital Partners

Seattle, U.S.A.

Investing In

IT (& TMT) • Hardware (& Manufacturing) • Cannabis

Description

Founded in 2018, AFI Capital Partners is a venture capital firm based in Seattle, Washington.

Investor Picture
Previous Investments
  • MJ Freeway: $10000000

Cresco Capital Partners

Dallas, U.S.A.

Investing In

Cannabis

Description

Cresco Capital Partners is a private investment firm that prefers to invest in the cannabis industry. The firm is based in Dallas, Texas.

Investor Picture
Previous Investments
  • Lincoln MGT:

Lincoln Property

Dallas, U.S.A.

Investing In

Other • BioTech • Energy • CleanTech • Cannabis • Life Science • Oncology

Description

Lincoln Property is a real estate firm engaged in asset & property management, construction management, development and build-to-suit services, investments/acquisitions, and landlord representation. The firm operates in the United States and Europe.

Investor Picture
Previous Investments
  • Altum Investments:

Granite Hall Partners

Chicago, U.S.A.

Investing In

Hardware (& Manufacturing) • Cannabis • Real Estate (& Construction) • Healthcare (& Wellness)

Description

Granite Hall Partners, LLC is a private fund of funds manager which creates alternative investment vehicles for institutional and high net worth investors. It is based in Chicago, Illinois. The firm was stablished in 2000, as Sports Venture Partners. It was later re-branded as Granite Hall Partners in 2008. The firm currently manages multi-manager funds in the following categories: leveraged buyouts, private real estate, alternative credit and hedge funds. It primarily invests in United States, Europe and Asia.

Join the community

Connect with investors & startup founders

Comprehensive Guides to Finding Investorsin the United states

By clicking on "Create Account" you accept our terms of service

Already have an account?
Login
Mike testimonial

Michael Colin - Founder of The MVMT



"We met the perfect Angel Investor within the Angels Partners Investors' Community. We received a $250,000 check after 2 months of discussions with investors on the platform."

Taylor Testimonial

Taylor Matter - Founder & CEO, Hurdle Apparel



"Raising Capital for a consumer venture can be rather difficult and Angels Partners helped connect the dots and helped us meet 2 investors who investors $200,000 in our brand."

founder clement

Clément Perrot - Co-Founder & CEO of Prynt



"Met really good investors who invested in Prynt, that I wouldn’t have met otherwise. Angels Partners helped us close our round quicker and with the right people."


Create An Account
Copyright © 2024 - All trademarks and copyrights belong to their respective owners.
proof notifcation
32 New StartupsStarted their fundraisingover the last 7 days